IRF-1/IL-12

Molecular group: 
Cytokines and receptors
Molecule/Cell: 
IRF-1/IL-12
Plasmodium strain: 
Plasmodium berghei ANKA
pRBC infection titer: 
10^6
Mouse genetic background (Con): 
C57BL/6
Level of backcrossing: 
N.I.
Experimental treatment group (EG): 
IRF-1 -/- + rIL-12
Lethal infection (Con): 
yes
Lethal infection (EG): 
yes
Pathology (Con): 
N.I.
Pathology (EG): 
N.I.
Parasitemia (EG vs Con): 
Delayed onset and decreased peak
Additional phenotypes (EG vs Con): 
Earlier death (days); no detectable NOS2 mRNA expression in brain or NO2- in serum; ↑ IFN-g production by ConA-stimulated spleen cells and in serum; ↑ IFN-g mRNA expression in brain, liver, spleen and kidney
Refs: 
Tan et al., 1999, Infect Immun